High cytoplasmic expression of Krüppel-like factor 4 is an independent prognostic factor of better survival in hepatocellular carcinoma

International Journal of Molecular Sciences

Volumn 15, Issue 6, 2014, Pages 9894-9906

  Hsu, Hui Ting ^a,b   Wu, Pei Ru ^a   Chen, Chih Jung ^a,b,c   Hsu, Li Sung ^b,d   Yeh, Chung Min ^a   Hsing, Ming Tai ^a   Chiang, Yi Shan ^a   Lai, Ming Tsung ^b,d   Yeh, Kun Tu ^a,b  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c JEN TEH JUNIOR COLLEGE OF MEDICINE   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Hepatocellular carcinoma; Immunohistochemical study; Ki 67; KLF4; Survival; Tissue microarray

Indexed keywords

CYTOPLASM PROTEIN; KI 67 ANTIGEN; KRUPPEL LIKE FACTOR 4; ONCOPROTEIN; TUMOR SUPPRESSOR PROTEIN; KRUPPEL LIKE FACTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CELL DIFFERENTIATION; CELL PROLIFERATION; COHORT ANALYSIS; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; TISSUE MICROARRAY; TUMOR DIFFERENTIATION; CARCINOMA, HEPATOCELLULAR; CYTOPLASM; KAPLAN MEIER METHOD; LIVER; LIVER NEOPLASMS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CYTOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 84901921434     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15069894     Document Type: Article

References (31)

1. Mittal, S.; El-Serag, H.B. Epidemiology of hepatocellular carcinoma: Consider the population. J. Clin. Gastroenterol. 2013, 47, S2-S6.
2. El-Serag, H.B. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012, 142, 1264-1273.
3. Wong, C.M.; Ng, I.O. Molecular pathogenesis of hepatocellular carcinoma. Liver Int. 2008, 28, 160-174.
4. Zucman-Rossi, J. Molecular classification of hepatocellular carcinoma. Dig. Liver Dis. 2010, 42 (Suppl. 3), S235-S241.
5. Zender, L.; Villanueva, A.; Tovar, V.; Sia, D.; Chiang, D.Y.; Llovet, J.M. Cancer gene discovery in hepatocellular carcinoma. J. Hepatol. 2010, 52, 921-929.
6. Wei, D.; Kanai, M.; Huang, S.; Xie, K. Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis 2006, 27, 23-31.
7. McConnell, B.B.; Yang, V.W. Mammalian Kruppel-like factors in health and diseases. Physiol. Rev. 2010, 90, 1337-1381.
8. Hu, R.; Zuo, Y.; Zuo, L.; Liu, C.; Zhang, S.; Wu, Q.; Zhou, Q.; Gui, S.; Wei, W.; Wang, Y. KLF4 expression correlates with the degree of differentiation in colorectal cancer. Gut Liver 2011, 5, 154-159.
9. Yang, W.T.; Zheng, P.S. Krüppel-like factor 4 functions as a tumor suppressor in cervical carcinoma. Cancer 2012, 118, 3691-702.
10. Yoon, O.; Roh, J. Downregulation of KLF4 and the Bcl-2/Bax ratio in advanced epithelial ovarian cancer. Oncol. Lett. 2012, 4, 1033-1036.
11. Zammarchi, F.; Morelli, M.; Menicagli, M.; di Cristofano, C.; Zavaglia, K.; Paolucci, A.; Campani, D.; Aretini, P.; Boggi, U.; Mosca, F. et al. KLF4 is a novel candidate tumor suppressor gene in pancreatic ductal carcinoma. Am. J. Pathol. 2011, 178, 361-372.
12. Liu, Z.; Yang, H.; Luo, W.; Jiang, Q.; Mai, C.; Chen, Y.; Zhen, Y.; Yu, X.; Long, X.; Fang, W. Loss of cytoplasmic KLF4 expression is correlated with the progression and poor prognosis of nasopharyngeal carcinoma. Histopathology 2013, 63, 362-370.
13. Hu, W.; Hofstetter, W.L.; Li, H.; Zhou, Y.; He, Y.; Pataer, A.; Wang, L.; Xie, K.; Swisher, S.G.; Fang, B. Putative tumor-suppressive function of Kruppel-like factor 4 in primary lung carcinoma. Clin. Cancer Res. 2009, 15, 5688-5695.
14. Zhang, Z.; Wang, Z.; Liu, X.; Shi, M.; Chen, G.; Zhang, B.; Li, Z.; Song, L. Correlation of KLF4 and SPARC expression with the clinical characteristics of non-small cell lung cancer. Chin. J. Lung Cancer 2012, 15, 720-724.
15. Ohnishi, S.; Ohnami, S.; Laub, F.; Aoki, K.; Suzuki, K.; Kanai, Y.; Haga, K.; Asaka, M.; Ramirez, F.; Yoshida, T. Downregulation and growth inhibitory effect of epithelial-type Krüppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochem. Biophys. Res. Commun. 2003, 308, 251-256.
16. Zhang, N.; Zhang, J.; Wang, Z.W.; Zha, L.; Huang, Z. Altered expression of Krüppel-like factor 4 and β-catenin in human gastric cancer. Oncol. Lett. 2012, 3, 1017-1022.
17. Li, H.; Wang, J.; Xiao, W.; Xia, D.; Lang, B.; Yu, G.; Guo, X.; Guan, W.; Wang, Z.; Hu, Z. et al. Epigenetic alterations of Kruppel-like factor 4 and its tumor suppressor function in renal cell carcinoma. Carcinogenesis 2013, 34, 2262-2270.
18. Chen, Y.J.; Wu, C.Y.; Chang, C.C.; Ma, C.J.; Li, M.C.; Chen, C.M. Nuclear Krüppel-like factor 4 expression is associated with human skin squamous cell carcinoma progression and metastasis. Cancer Biol. Ther. 2008, 7, 777-782.
19. Li, Q.; Gao, Y.; Jia, Z.; Mishra, L.; Guo, K.; Li, Z.; Le, X.; Wei, D.; Huang, S.; Xie, K. Dysregulated Krüppel-like factor 4 and Vitamin D receptor signaling contribute to progression of hepatocellular carcinoma. Gastroenterology 2012, 143, 799-810.
20. Yin, X.; Li, Y.W.; Jin, J.J.; Zhou, Y.; Ren, Z.G.; Qiu, S.J.; Zhang, B.H. The clinical and prognostic implications of pluripotent stem cell gene expression in hepatocellular carcinoma. Oncol. Lett. 2013, 5, 1155-1162.
21. Pandya, A.Y.; Talley, L.I.; Frost, A.R.; Fitzgerald, T.J.; Trivedi, V.; Chakravarthy, M.; Chhieng, D.C.; Grizzle, W.E.; Engler, J.A.; Krontiras, H. et al. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin. Cancer Res. 2004, 10, 2709-2719.
22. Liu, Y.; Zheng, B.; Zhang, X.H.; Nie, C.J.; Li, Y.H.; Wen, J.K. Localization and function of KLF4 in cytoplasm of vascular smooth muscle cell. Biochem. Biophys. Res. Commun. 2013, 436, 162-168.
23. Le Magnen, C.; Bubendorf, L.; Ruiz, C.; Zlobec, I.; Bachmann, A.; Heberer, M.; Spagnoli, G.C.; Wyler, S.; Mengus, C. KLF4 transcription factor is expressed in the cytoplasm of prostate cancer cells. Eur. J. Cancer 2013, 49, 955-963.
24. D'Errico, A.; Grigioni, W.F.; Fiorentino, M.; Baccarini, P.; Grazi, G.L.; Mancini, A.M. Overexpression of p53 protein and Ki-67 proliferative index in hepatocellular carcinoma: An immuno-histochemical study on 109 Italian patients. Pathol. Int. 1994, 44, 682-687.
25. Nakanishi, K.; Sakamoto, M.; Yamasaki, S.; Todo, S.; Hirohashi, S. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma. Cancer 2005, 103, 307-312.
26. Tuominen, V.J.; Ruotoistenmäki, S.; Viitanen, A.; Jumppanen, M.; Isola, J. ImmunoRatio: A publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Res. 2010, 12, R56.
27. Han, D.H.; Choi, G.H.; Kim, K.S.; Choi, J.S.; Park, Y.N.; Kim, S.U.; Park, J.Y.; Ahn, S.H.; Han, K.H. Prognostic significance of the worst grade in hepatocellular carcinoma with heterogeneous histologic grades of differentiation. J. Gastroenterol. Hepatol. 2013, 28, 1384-1390.
28. Qin, L.X.; Tang, Z.Y. The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J. Gastroenterol. 2002, 8, 193-199.
29. Chen, C.J.; Hsu, L.S.; Lin, S.H.; Chen, M.K.; Wang, H.K.; Hsu, J.D.; Lee, H.; Yeh, K.T. Loss of nuclear expression of Krüppel-like factor 4 is associated with poor prognosis in patients with oral cancer. Hum. Pathol. 2012, 43, 1119-1125.
30. Tai, S.K.; Yang, M.H.; Chang, S.Y.; Chang, Y.C.; Li, W.Y.; Tsai, T.L.; Wang, Y.F.; Chu, P.Y.; Hsieh, S.L. Persistent Krüppel-like factor 4 expression predicts progression and poor prognosis of head and neck squamous cell carcinoma. Cancer Sci. 2011, 102, 895-902.
31. Li, J.; Zheng, H.; Yu, F.; Yu, T.; Liu, C.; Huang, S.; Wang, T.C.; Ai, W. Deficiency of the Kruppel-like factor KLF4 correlates with increased cell proliferation and enhanced skin tumorigenesis. Carcinogenesis 2012, 33, 1239-1246.